Most Read Articles
3 days ago
Cardiac biomarkers are useful for identifying community-acquired pneumonia (CAP) patients with an elevated risk of early and long-term cardiovascular (CV) events, according to a study.
Yesterday
Tofogliflozin is safe and effective for elderly patients with type 2 diabetes mellitus (T2DM), regardless of insulin and oral antidiabetic drugs, reports a new Japan study.
6 days ago
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.
5 days ago
Systolic blood pressure appears to have a strong association with aneurysmal subarachnoid haemorrhage (aSAH) but not with unruptured intracranial aneurysm (UIA), whereas current smoking and female sex are risk factors for both conditions, a study has found.

Scalp cooling device effective in reducing chemo-induced alopecia in breast cancer patients

Audrey Abella
28 Dec 2018

Use of a scalp cooling device is effective in reducing alopecia or hair loss in patients with breast cancer who are undergoing neoadjuvant/adjuvant chemotherapy including anthracyclines* and taxanes**, according to studies presented at SABCS 2018.

A prospective analysis evaluated 118 women (median age 44 years) with early/locally advanced breast cancer sequentially treated with thrice-weekly docetaxel/cyclophosphamide, epirubicin 90 mg/m2, or cyclophosphamide 600 mg/m2, followed by 12 courses of weekly paclitaxel 80 mg/m2. Hair loss was estimated using the Dean scale*** by evaluating photographs of the head during and 1 month following chemotherapy. [SABCS 2018, abstract P1-11-03]

Treatment success (≤50 percent hair loss, Dean scale score of 0–2) was achieved in 87.3 percent of participants, 35.6 percent of whom reported no hair loss.

Toxicities reported were grade 1/2 headache (47.4 percent), cervical discomfort (30.5 percent), and skin pain (8.5 percent). The prime reason for discontinuing the use of the device was Dean scale G3 hair loss (12.7 percent), followed by discomfort (6.8 percent) and headache (3.4 percent).

Another prospective evaluation on 143 Japanese women (median age 50 years) with breast cancer who were receiving neoadjuvant chemotherapy generated similar results after 1 month. Of these, 129 completed a chemotherapy regimen of 4–8 cycles. The scalp cooling device was used 30 minutes prior to, during, and 90 minutes after each infusion. [SABCS 2018, abstract P4-16-13]

Those who continued to use the scalp cooling device throughout the planned course of chemotherapy had significantly lower rates of grade 3 alopecia (hair loss >50 percent) than those who discontinued the device by day 10 of cycle one (45.6 percent vs 89.3 percent; p=0.0001).

The findings support previous evidence showing the efficacy of scalp cooling among women undergoing a non-anthracycline based chemotherapy regimen for breast cancer. [JAMA 2017;317:606-614] Moreover, the current results may address other issues associated with scalp cooling, which has been reported to be dependent on factors such as the type of chemotherapy regimen, dosing, and schedule, as well as the type of scalp cooling device or system used. [Oncologist 2013;18:885-891; Ann Oncol 2005;16:352-358]

Taken together, the findings provide insight for breast cancer patients afflicted with or troubled by chemotherapy-induced alopecia, which is a common adverse effect that could be emotionally taxing for patients, said the researchers, noting that a successful scalp cooling regimen could improve patients’ treatment experience and quality of life, and mitigate feelings of disappointment regarding physical appearance.

 

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
3 days ago
Cardiac biomarkers are useful for identifying community-acquired pneumonia (CAP) patients with an elevated risk of early and long-term cardiovascular (CV) events, according to a study.
Yesterday
Tofogliflozin is safe and effective for elderly patients with type 2 diabetes mellitus (T2DM), regardless of insulin and oral antidiabetic drugs, reports a new Japan study.
6 days ago
Pulmonary function has potential predictive value for future increases in arterial stiffness and its progression, as reported in a recent study.
5 days ago
Systolic blood pressure appears to have a strong association with aneurysmal subarachnoid haemorrhage (aSAH) but not with unruptured intracranial aneurysm (UIA), whereas current smoking and female sex are risk factors for both conditions, a study has found.